Chlordiazepoxide loses its anxiolytic action with long-term treatment
- PMID: 35809
- DOI: 10.1007/BF00426036
Chlordiazepoxide loses its anxiolytic action with long-term treatment
Abstract
The biochemical and behavioural effects of acute, 5, 15 and 25 days treatment with chlordiazepoxide (CDP, 5 mg/kg) were examined in the rat. After 5 days of drug treatment, 5-hydroxytryptamine (5HT) levels in the midbrain, hypothalamus and cortex were significantly higher than those of the corresponding controls, and the level of 5-hydroxyindoleacetic acid (5HIAA) was significantly lower, indicating reduced turnover. After 15 days of drug treatment, 5HIAA levels were significantly elevated, compared with the controls, possibly indicating that CDP was blocking the transport of 5HIAA from the brain. This effect appears to be independent of the reduced turnover. After 25 days of drug treatment there were no significant differences compared with the controls. There were no marked changes in noradrenaline and dopamine in any of the areas investigated. It appears that the reduction in 5HT turnover is linked to the anxiolytic effects of CDP; the latter were found after 5 days of drug treatment, but not after 15 or 25 days, using the social interaction test of anxiety.
Similar articles
-
Evidence that piracetam has an anxiolytic action.J Affect Disord. 1979 Dec;1(4):227-35. doi: 10.1016/0165-0327(79)90009-0. J Affect Disord. 1979. PMID: 95599
-
Changes in regional concentrations in the rat brain of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid during the development of tolerance to the sedative action of chlordiazepoxide.J Pharm Pharmacol. 1983 Sep;35(9):601-3. doi: 10.1111/j.2042-7158.1983.tb04344.x. J Pharm Pharmacol. 1983. PMID: 6195324 No abstract available.
-
Time course of bromocriptine induced excitation in the rat: behavioural and biochemical studies.Naunyn Schmiedebergs Arch Pharmacol. 1995 Feb;351(2):146-55. doi: 10.1007/BF00169328. Naunyn Schmiedebergs Arch Pharmacol. 1995. PMID: 7539523
-
Chlordiazepoxide, go-nogo successive discrimination and brain biogenic amines in cats.Pharmacol Biochem Behav. 1984 Jan;20(1):9-22. doi: 10.1016/0091-3057(84)90093-5. Pharmacol Biochem Behav. 1984. PMID: 6198668
-
Studies on the role of ACTH and of 5-HT in anxiety, using an animal model.J Pharm Pharmacol. 1978 Feb;30(2):105-10. doi: 10.1111/j.2042-7158.1978.tb13172.x. J Pharm Pharmacol. 1978. PMID: 24093
Cited by
-
Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze.Psychopharmacology (Berl). 1990;102(1):98-101. doi: 10.1007/BF02245751. Psychopharmacology (Berl). 1990. PMID: 1975449
-
A possible olfactory component in the effects of diazepam on social behavior of mice.Psychopharmacology (Berl). 1982;77(3):246-52. doi: 10.1007/BF00464575. Psychopharmacology (Berl). 1982. PMID: 6812147
-
Chronic treatment with Ro 15-1788 distinguishes between its benzodiazepine antagonist, agonist and inverse agonist properties.Psychopharmacology (Berl). 1986;89(1):113-7. doi: 10.1007/BF00175201. Psychopharmacology (Berl). 1986. PMID: 3090585
-
Animal models of drug withdrawal symptoms.Psychopharmacology (Berl). 1990;101(3):292-309. doi: 10.1007/BF02244046. Psychopharmacology (Berl). 1990. PMID: 1972994 Review.
-
Tolerance to the anti-pentylenetetrazole effects of diazepam in the mouse.Psychopharmacology (Berl). 1983;79(2-3):284-6. doi: 10.1007/BF00427828. Psychopharmacology (Berl). 1983. PMID: 6405440
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources